This presentation covers:

• What impact substantial changes in the pharma industry have on Pharma MES and where to allocate MES in the future
• MES as part of a bigger picture: business drivers, challenges and opportunities
• Is MES still the heartbeat of the factory of the future or does MES fulfill another task in the future?
• Passing of the automation pyramid and step into transition phase
• Use of AI and e.g. new linguistic software